Published On: 10/29/2024

DIA RWE 2024 Research: Presentation by Nuvan Rathnayaka

At Target RWE, we are dedicated to enhancing the reliability and reproducibility of real-world evidence (RWE). Our latest research from the DIA Real-World Evidence (RWE) 2024 conference delves into advanced strategies designed to sharpen inter-team communication and minimize potential errors in RWE studies. Nuvan Rathnayaka, Target RWE Manager of Biostatistics, provides insights into this innovative approach and discusses how effective communication frameworks can drive more accurate real-world data analysis.

Watch the video below to gain a first-hand look at the presented research titled 'Seeing Eye to Eye: Enhancing Inter-Team Communication for Reproducible Real-World Evidence.'

About Target RWE

Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.

Visit our website to learn more: https://targetrwe.com/

Contact:

Kayla Slake
Senior Manager, Marketing

kslake@targetrwe.com

984.234.0268 ext 205